Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Combined Synopsis/Solicitation opportunity from Department Of Defense was posted on September 22, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Ibandronate Sodium Tablets

Awarded
SPE2D2-25-R-0019Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The Defense Logistics Agency (DLA) Troop Support is soliciting proposals for a national requirements contract to supply Ibandronate Sodium 150MG tablets packaged in 3-count packs. This procurement is unrestricted and fully competitive, conducted as a firm-fixed-price contract under FAR Part 12 for commercial items. The contract includes a one-year base period plus four one-year option periods, establishing a national supply source to serve multiple federal agencies including the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons through the DLA and VA prime vendor programs. Annual usage estimates will be provided in the solicitation’s Schedule of Supplies, and deliveries will be made based on actual requirements as outlined in FAR 52.216-21 (Requirements). The solicitation, number SPE2D2-25-R-0019, is scheduled for release around July 2025, with proposal submissions due by October 10, 2025, and all interested vendors may submit proposals electronically via the DLA Bid Board System (DIBBS) and SAM.gov. The contract’s performance and delivery will be managed nationally via DLA’s logistics infrastructure with administrative offices located in Philadelphia, PA. Packaging will conform to commercial standards, and items must be clearly marked as Ibandronate Sodium 150MG with the assigned National Stock Number (NSN) 7540-01-152-8070. Although specific detailed line-item pricing and quantities are not publicly disclosed, the solicitation references annual usage estimates and outlines the firm-fixed-price nature of the contract. Amendments to the solicitation, including extensions of the proposal due date, have been issued and require formal acknowledgment by offerors to maintain proposal eligibility. Inspection and acceptance criteria rely on commercial standards compliant with FAR Part 12, with the government responsible for final acceptance. Representations, certifications, and compliance with all applicable federal acquisition regulations are required from offerors, who must have active SAM registration including a unique entity identifier and CAGE code. This solicitation facilitates streamlined procurement of pharmaceutical products to ensure consistent supply to federal health and correctional institutions.

General Info

DLA seeks national firm-fixed-price contract for Ibandronate Sodium 150MG, one-year base plus options.

Contract Value

$0

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

PA, USA

Set-Aside

NONE

Award Issued Date

Documents

3

Amendment 0002 to Solicitation SPE2D225R0019

PDF, High priority: read this first2 pages · amendment
High

Solicitation SPE2D2-25-R-0019: Ibandronate Sodium

PDF, High priority: read this first91 pages · rfp
High

SPE2D225R0019 Amendment 0001

PDF, High priority: read this first2 pages · amendment
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

2 updates
PhaseAwarded
Posted

Presolicitation

Type Changed

Presolicitation → Combined Synopsis

Notice updated

Notice details unchanged. Attachments may have changed.

Deadline changed

Response deadline changed from Sep 22, 2025 to Oct 6, 2025.

Awarded

Contract was awarded

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → DLA Troop Support
Contacts2 people available
OfficePHILADELPHIA, PA, 19111, USA
Office AddressPHILADELPHIA, PA, 19111, USA

Full Description

Show more
SPE2D2-25-R-0019 Ibandronate Sodium Tablets

More opportunities from Department Of Defense → DLA Troop Support

Same awarding agency

NAICS: 326199
New
Federal
Synopsis for Outserts (NSN - 4240-01-529-8327 & 4240-01-528-9288)
Solicitation # 015298327_015289288
Solicitation SPE8EG-26-R-0003 is an unrestricted, fixed-price with economic price adjustment, indefinite delivery/indefinite quantity contract issued by DLA Troop Support. The procurement is for critical Chemical Biological Radiation and Nuclear Personal Protective Equipment, specifically Clear Assembly Outserts (NSN 4240-01-529-8327) and Laser Assembly Outserts (NSN 4240-01-528-9288). The contract structure consists of a one-year base period and four one-year option periods, with a target delivery schedule of 100 days and terms set as FOB Origin. Avon Protection Systems Incorporated is the approved source, and while alternate offers are encouraged via specific DLAD procurement notes, they require a complete data package for evaluation. The solicitation has undergone five amendments, with the final closing date extended to September 2, 2026, at 3:00 PM EDT. Key regulatory requirements include compliance with the Buy American Act, the Berry Amendment, and export-control regulations under ITAR and EAR, requiring offerors to have approved US/Canada Joint Certification Program certification. Additionally, the contract incorporates FAR 52.222-90 regarding DEI discrimination and clarifies that while Cybersecurity Maturity Model Certification Level 2 is not required for the initial award, it may be necessary for future continued performance. Price is the sole evaluated factor for award.
All Other Plastics Product Manufacturing

POSTED

about 10 hours ago

DEADLINE

in 16 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS